IP Library Granted Patent US 10,527,618
Granted Patent B2
US 10,527,618 · App. 14/917,632 · Granted Jan 7, 2020

Sample processing method for influenza virus immunoassay, and immunoassay method

Inventors: Yuki Shinohara (Gosen, JP); Takashi Miyazawa (Gosen, JP)
Assignee: DENKA SEIKEN CO., LTD.
G01N33/56983G01N2333/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,527,618
App. No.
14/917,632
Granted
Jan 7, 2020
Kind
B2
Abstract

Means for enabling an immunoassay with a sufficient sensitivity in an immunoassay for measuring influenza virus in a sample using influenza virus M1 protein as an antigen is provided. A sample processing method in an immunoassay for influenza virus, which method comprises, in an immunoassay for influenza virus using an antibody which undergoes antigen-antibody reaction with influenza virus matrix 1 protein, or an antigen-binding fragment thereof, bringing a sample containing influenza virus into contact with a sample processing liquid containing a surfactant having at least one group selected from the group consisting of palmityl, stearyl, and oleyl, is provided.

Claims (8)

1. A sample processing method for an immunoassay for influenza virus matrix 1 protein, said sample processing method comprising:

bringing a sample containing influenza virus matrix 1 protein into contact with a sample processing liquid containing:

a surfactant comprising polyoxyethylene cetyl ether, and

an alkali metal chloride with the final concentration of said chloride in said sample processing liquid being 0.3 to 1 M to produce a processed sample,

said immunoassay for influenza virus matrix 1 protein including:

contacting the processed sample including influenza virus matrix 1 protein with an antibody or antigen binding fragment thereof which specifically binds influenza virus matrix 1 protein, said contacting being carried out in the presence of the surfactant added during the sample processing method.

2. The method according to claim 1 , wherein the final concentration of said surfactant in said sample processing liquid is 0.005 (w/v) % to 8 (w/v) %.

3. The method according to claim 2 , wherein said final concentration of surfactant in said sample processing liquid is 0.5 (w/v) % to 4 (w/v) %.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2016
From: SHINOHARA, YUKI; MIYAZAWA, TAKASHI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 038140/0310 →
Priority Claims (1)
JP 2013-187355 · Sep 10, 2013 · national
Continuity (1)
Related Publication 20160223540A1 · Aug 4, 2016